EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications

Bao T Le, Suxiang Chen iD, Rakesh N Veedu

Biomolecules · 22.07.2024 · 14 (7) · 883

DOI: 10.3390/biom14070883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.07.2024. Verfasst von Bao T Le und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, RNA Splicing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: McCusker Charitable Foundation, Perron Institute for Neurological and Translational Science, ProGenis Pharmaceuticals Pty Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic antisense oligonucleotides (ASOs) are emerging as an attractive platform to treat various diseases. By specifically binding to a target mRNA transcript through Watson–Crick base pairing, ASOs can alter gene expression in a desirable fashion to either rescue loss of function or downregulate pathogenic protein expression. To be clinically relevant, ASOs are generally synthesized using modified analogs to enhance resistance to enzymatic degradation and pharmacokinetic and dynamic properties. Phosphorothioate (PS) belongs to the first generation of modified analogs and has played a vital role in the majority of approved ASO drugs, mainly based on the RNase H mechanism. In contrast to RNase H-dependent ASOs that bind and cleave target mature mRNA, splice-switching oligonucleotides (SSOs) mainly bind and alter precursor mRNA splicing in the cell nucleus. To date, only one approved SSO (Nusinersen) possesses a PS backbone. Typically, the synthesis of PS oligonucleotides generates two types of stereoisomers that could potentially impact the ASO’s pharmaco-properties. This can be limited by introducing the naturally occurring phosphodiester (PO) linkage to the ASO sequence. In this study, towards fine-tuning the current strategy in designing SSOs, we reported the design, synthesis, and evaluation of several stereo-random SSOs on a mixed PO–PS backbone for their binding affinity, biological potency, and nuclease stability. Based on the results, we propose that a combination of PO and PS linkages could represent a promising approach toward limiting undesirable stereoisomers while not largely compromising the efficacy of SSOs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisenseRNA SplicingHumansPhosphorothioate OligonucleotidesRibonuclease HDrug Design

Stichwörter der Autor:innen

antisense oligonucleotidebinding affinityexon skippingnuclease stabilityphosphodiesterphosphorothioatesplice-switching oligonucleotide

Substanzen

Oligonucleotides, AntisensePhosphorothioate OligonucleotidesRibonuclease H

Autor:innen und Institutionen

  • Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia.
  • ProGenis Pharmaceuticals Pty Ltd., Bentley, WA 6102, Australia.
  • Precision Nucleic Acid Therapeutics, Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.

ORCID-Profile: Suxiang Chen

Förderung

  • McCusker Charitable Foundation
  • Perron Institute for Neurological and Translational Science
  • ProGenis Pharmaceuticals Pty Ltd.

Zitieren

APA

Le, B. T., Chen, S., & Veedu, R. N. (2024). Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications. Biomolecules, 14(7), 883. https://doi.org/10.3390/biom14070883

Vancouver

Le BT, Chen S, Veedu RN. Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications. Biomolecules. 2024;14(7):883. doi:10.3390/biom14070883

BibTeX
@article{Le2024,
  author = {Le, Bao T and Chen, Suxiang and Veedu, Rakesh N},
  title = {Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {883},
  doi = {10.3390/biom14070883}
}
Kostenlos starten →